These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
407 related items for PubMed ID: 14647449
1. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M, Safe S. Oncogene; 2004 Feb 05; 23(5):1052-63. PubMed ID: 14647449 [Abstract] [Full Text] [Related]
2. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M. Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749 [Abstract] [Full Text] [Related]
3. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ. J Endocrinol; 2006 Dec 01; 191(3):605-12. PubMed ID: 17170218 [Abstract] [Full Text] [Related]
4. Vascular endothelial growth factor receptor-2 expression is induced by 17beta-estradiol in ZR-75 breast cancer cells by estrogen receptor alpha/Sp proteins. Higgins KJ, Liu S, Abdelrahim M, Yoon K, Vanderlaag K, Porter W, Metz RP, Safe S. Endocrinology; 2006 Jul 01; 147(7):3285-95. PubMed ID: 16574784 [Abstract] [Full Text] [Related]
5. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Kawai H, Li H, Chun P, Avraham S, Avraham HK. Oncogene; 2002 Oct 31; 21(50):7730-9. PubMed ID: 12400015 [Abstract] [Full Text] [Related]
6. Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ERDelta3. Koduri S, Goldhar AS, Vonderhaar BK. Breast Cancer Res Treat; 2006 Jan 31; 95(1):37-43. PubMed ID: 16267616 [Abstract] [Full Text] [Related]
7. Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells. Khan S, Abdelrahim M, Samudio I, Safe S. Endocrinology; 2003 Jun 31; 144(6):2325-35. PubMed ID: 12746293 [Abstract] [Full Text] [Related]
8. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc. Dadiani M, Seger D, Kreizman T, Badikhi D, Margalit R, Eilam R, Degani H. Endocr Relat Cancer; 2009 Sep 31; 16(3):819-34. PubMed ID: 19398483 [Abstract] [Full Text] [Related]
9. Estrogen-dependent regulation of ornithine decarboxylase in breast cancer cells through activation of nongenomic cAMP-dependent pathways. Qin C, Samudio I, Ngwenya S, Safe S. Mol Carcinog; 2004 Jul 31; 40(3):160-70. PubMed ID: 15224348 [Abstract] [Full Text] [Related]
10. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Abdelrahim M, Smith R, Burghardt R, Safe S. Cancer Res; 2004 Sep 15; 64(18):6740-9. PubMed ID: 15374992 [Abstract] [Full Text] [Related]
11. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells. Liang Y, Wu J, Stancel GM, Hyder SM. J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):173-82. PubMed ID: 15860260 [Abstract] [Full Text] [Related]
12. 17beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways. Ru Lee W, Chen CC, Liu S, Safe S. J Cell Biochem; 2006 Sep 01; 99(1):209-20. PubMed ID: 16598773 [Abstract] [Full Text] [Related]
13. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Abdelrahim M, Safe S. Mol Pharmacol; 2005 Aug 01; 68(2):317-29. PubMed ID: 15883203 [Abstract] [Full Text] [Related]
14. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins. Higgins KJ, Abdelrahim M, Liu S, Yoon K, Safe S. Biochem Biophys Res Commun; 2006 Jun 23; 345(1):292-301. PubMed ID: 16678129 [Abstract] [Full Text] [Related]
15. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway. Sengupta K, Banerjee S, Saxena N, Banerjee SK. Int J Oncol; 2003 Mar 23; 22(3):609-14. PubMed ID: 12579315 [Abstract] [Full Text] [Related]
16. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. Kim K, Thu N, Saville B, Safe S. Mol Endocrinol; 2003 May 23; 17(5):804-17. PubMed ID: 12576490 [Abstract] [Full Text] [Related]
17. Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor alpha through its interaction with Sp1. Panno ML, Mauro L, Marsico S, Bellizzi D, Rizza P, Morelli C, Salerno M, Giordano F, Andò S. J Mol Endocrinol; 2006 Feb 23; 36(1):91-105. PubMed ID: 16461930 [Abstract] [Full Text] [Related]
18. Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Kazi AA, Jones JM, Koos RD. Mol Endocrinol; 2005 Aug 23; 19(8):2006-19. PubMed ID: 15774498 [Abstract] [Full Text] [Related]
19. 17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells. Sisci D, Middea E, Morelli C, Lanzino M, Aquila S, Rizza P, Catalano S, Casaburi I, Maggiolini M, Andò S. Breast Cancer Res Treat; 2010 Nov 23; 124(1):63-77. PubMed ID: 20052536 [Abstract] [Full Text] [Related]
20. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. Hantusch B, Kalt R, Krieger S, Puri C, Kerjaschki D. BMC Mol Biol; 2007 Mar 07; 8():20. PubMed ID: 17343736 [Abstract] [Full Text] [Related] Page: [Next] [New Search]